On the safety and effectiveness of COVID-19 vaccines, certainties and uncertainties
Introduction: The COVID-19 vaccines in use (inactivaded virus, encapsulated m-RNA, non-replicating adenovirus-vectored DNA) were clinically tested in randomized placebocontrolled phase-3 studies. Objective: To address certainties and uncertainties about safety and effectiveness of COVID-19 vaccines...
Main Authors: | Ana Cecilia Amado Xavier de Oliveira, Isabella Fernandes Delgado, Francisco José Roma Paumgartten |
---|---|
Format: | Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
2021-08-01
|
Series: | Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia |
Subjects: | |
Online Access: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1881 |
Similar Items
-
Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review
by: Martina Amanzio, et al.
Published: (2022-01-01) -
The Adverse Event Paradox
by: Thomas Milovac
Published: (2022-05-01) -
Ethical considerations on placebo-controlled vaccine trials in pregnant women
by: Ana Cecilia Amado Xavier de Oliveira, et al.
Published: (2023-05-01) -
Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
by: Jenna Rose Stoehr, et al.
Published: (2021-06-01) -
Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial
by: T. Michnevich, et al.
Published: (2022-09-01)